Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers

PHASE3CompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
AsthmaAsthma ExacerbationsPreschool ChildVitamin DUpper Respiratory InfectionRandomized Controlled StudySymptomsBronchodilator Agents
Interventions
DIETARY_SUPPLEMENT

Vitamin D

2 mL of 50,000 IU/mL at baseline and at 3.5 months with a daily dose of 1 mL (400 IU/mL) for 7 months

DIETARY_SUPPLEMENT

Placebo

2 mL of placebo at baseline and at 3.5 months with a daily dose of placebo (1 mL) for 7 months

Trial Locations (9)

V6H 3V4

British Columbia Children's Hospital, Vancouver

N6A 2V5

Children's Hospital of London Health Sciences Centre, London

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

M5G 1X8

The Hospital for Sick Children, Toronto

H3H 1P3

Montreal Children's Hospital, Montreal

H3T1C5

CHU Sainte Justine, Montreal

Unknown

Maisonneuve-Rosemont Hospital, Montreal

G1V 4G2

CHU de Québec-Université Laval, Québec

J1G 2E8

CHU de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

EURO-PHARM International Canada, Inc.

OTHER

lead

Professor Francine Ducharme

OTHER

NCT03365687 - Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers | Biotech Hunter | Biotech Hunter